Nevro Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $1.66 billion. The enterprise value is $4.31 billion.
Important Dates
The last earnings date was Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 67.90 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | 67.63M |
| Shares Outstanding | 67.90M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 0.87% |
| Owned by Institutions (%) | 108.13% |
| Float | 62.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.87 |
| PS Ratio | 0.60 |
| Forward PS | 0.59 |
| PB Ratio | 0.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 127.44 |
| P/OCF Ratio | 8.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of 331.23.
| EV / Earnings | n/a |
| EV / Sales | 1.57 |
| EV / EBITDA | 7.43 |
| EV / EBIT | 30.26 |
| EV / FCF | 331.23 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.00.
| Current Ratio | 1.12 |
| Quick Ratio | 0.48 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 4.41 |
| Debt / FCF | 215.52 |
| Interest Coverage | 0.78 |
Financial Efficiency
Return on equity (ROE) is -15.63% and return on invested capital (ROIC) is 1.54%.
| Return on Equity (ROE) | -15.63% |
| Return on Assets (ROA) | 1.36% |
| Return on Invested Capital (ROIC) | 1.54% |
| Return on Capital Employed (ROCE) | 2.72% |
| Revenue Per Employee | $415,394 |
| Profits Per Employee | -$70,667 |
| Employee Count | 6,600 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, QuidelOrtho has paid $58.30 million in taxes.
| Income Tax | 58.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.11% in the last 52 weeks. The beta is -0.03, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -39.11% |
| 50-Day Moving Average | 28.15 |
| 200-Day Moving Average | 35.40 |
| Relative Strength Index (RSI) | 40.98 |
| Average Volume (20 Days) | 1,612,003 |
Short Selling Information
The latest short interest is 6.25 million, so 9.20% of the outstanding shares have been sold short.
| Short Interest | 6.25M |
| Short Previous Month | 5.87M |
| Short % of Shares Out | 9.20% |
| Short % of Float | 10.02% |
| Short Ratio (days to cover) | 3.68 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.74 billion and -$466.40 million in losses. Loss per share was -$6.92.
| Revenue | 2.74B |
| Gross Profit | 1.30B |
| Operating Income | 142.30M |
| Pretax Income | -1.99B |
| Net Income | -466.40M |
| EBITDA | 579.40M |
| EBIT | 142.30M |
| Loss Per Share | -$6.92 |
Full Income StatementBalance Sheet
The company has $152.60 million in cash and $2.80 billion in debt, giving a net cash position of -$2.65 billion or -$39.02 per share.
| Cash & Cash Equivalents | 152.60M |
| Total Debt | 2.80B |
| Net Cash | -2.65B |
| Net Cash Per Share | -$39.02 |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 41.25 |
| Working Capital | 139.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $200.40 million and capital expenditures -$187.40 million, giving a free cash flow of $13.00 million.
| Operating Cash Flow | 200.40M |
| Capital Expenditures | -187.40M |
| Free Cash Flow | 13.00M |
| FCF Per Share | $0.19 |
Full Cash Flow StatementMargins
Gross margin is 47.29%, with operating and profit margins of 5.19% and -17.01%.
| Gross Margin | 47.29% |
| Operating Margin | 5.19% |
| Pretax Margin | -14.89% |
| Profit Margin | -17.01% |
| EBITDA Margin | 21.13% |
| EBIT Margin | 5.19% |
| FCF Margin | 0.47% |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.82% |
| Earnings Yield | -28.15% |
| FCF Yield | 0.78% |
Dividend DetailsAnalyst Forecast
The average price target for QuidelOrtho is $42.57, which is 74.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.57 |
| Price Target Difference | 74.47% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 2.19% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.93 |
| Piotroski F-Score | 5 |
